comparemela.com

Latest Breaking News On - Wellthy therapeutics - Page 4 : comparemela.com

Wellthy Therapeutics adds Beyond Next Ventures as an investor Expands into Japan

(This story has not been edited by THE WEEK and is auto-generated from a PTI

Abhishek shahYuichiro sanoKarthik varadaRanjan pai manipal family officeBeyond next venturesWellthy therapeuticsSouth asiaWellthy therapeuticBeyond nextSaama capitalGrowx venturesRanjan paiFamily officeNext ventures

Wellthy Therapeutics adds Beyond Next Ventures as an investor; Expands into Japan

PRNewswire, Mumbai, June 15: Wellthy Therapeutics is proud to announce that it has secured additional financing, led by Beyond Next Ventures, a venture capital firm based in Japan, with participation from existing investors.

Abhishek shahKarthik varadaYuichiro sanoRanjan pai manipal family officeWellthy therapeuticsBeyond next venturesSouth asiaWellthy therapeuticBeyond nextSaama capitalGrowx venturesRanjan paiFamily officeNext venturesDisclaimer the

Wellthy Therapeutics announces expansion into US

To revolutionise digital health worldwide with modular SaMD platform

United statesWellthy therapeuticsWellthy therapeutic

Wellthy Therapeutics announces expansion into the United States - completes FDA CFR Part 11, FDA CFR Part 820, and HIPAA Certification for its platform

Wellthy Therapeutics announces expansion into the United States - completes FDA CFR Part 11, FDA CFR Part 820, and HIPAA Certification for its platform
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

United statesAbhishek shahLos angelesWellthy therapeuticsWellthy therapeutic

Business News | Wellthy Therapeutics Announces Expansion into the United States - Completes FDA CFR Part 11, FDA CFR Part 820, and HIPAA Certification for Its Platform

Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India]/ Los Angeles (California) [US], May 11 (ANI/PRNewswire): Wellthy Therapeutics, a global leader in digital health and digital therapeutics, announces the successful completion of its FDA 21 CFR Part 820, FDA 21 CFR Part 11, and HIPAA certification for its disease-agnostic, modular, software-as-a-medical-device (SaMD) platform. These international registrations further solidify the company s commitment to maintaining the highest standards of data security, data privacy, quality and regulatory compliance in the development and manufacturing of digital health solutions for customers in the United States, and worldwide, and reinforce its leadership in the SaMD space. Business News | Wellthy Therapeutics Announces Expansion into the United States - Completes FDA CFR Part 11, FDA CFR Part 820, and HIPAA Certification for Its Platform.

United statesAbhishek shahLos angelesWellthy therapeuticsClick to find all new featuresEligible devicesWellthy therapeutic

vimarsana © 2020. All Rights Reserved.